Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247828 · ClinicalTrials.gov registry record · NA
Adaptive and Individualized AAC
A NA study, sponsored by Altec.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04247828: Completed NA study, sponsored by Altec.
NCT04247828 is a NA study that has completed, run by Altec. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04247828, a NA study, has completed, sponsored by Altec.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.
Primary Outcome
Time needed to navigate a cursor to and select a target on a computer screen by control of head movement and facial muscle contractions for each AAC device, wherein lower movement times equate to better performance.
Interventions
- DEVICE Experimental AAC
- DEVICE Generic AAC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT04247828 record still lists
NCT04247828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental AAC is the first listed.
NCT04247828 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04247828 about?
NCT04247828 is a clinical study titled "Adaptive and Individualized AAC". This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.
What is the current status of trial NCT04247828?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-01-06. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT04247828?
The interventions under investigation include: Experimental AAC (DEVICE), Generic AAC (DEVICE).
Who is sponsoring clinical trial NCT04247828?
This trial is sponsored by Altec, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04247828's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI